Screening trematodes for novel intervention targets: a proteomic and
          immunological comparison of Schistosoma haematobium, Schistosoma bovis
          and Echinostoma caproni by HIGÓN, MELISSA et al.
Screening trematodes for novel intervention targets: a
proteomic and immunological comparison of
Schistosoma haematobium, Schistosoma bovis
and Echinostoma caproni
MELISSA HIGÓN
1,2, GRAEME COWAN
1,N O R M A NN A U S C H
1,
DAVID CAVANAGH
1, ANA OLEAGA
4, RAFAEL TOLEDO
2, J. RUSSELL STOTHARD
6,
ORETO ANTÚNEZ
5, ANTONIO MARCILLA
2, RICHARD BURCHMORE
3
and FRANCISCA MUTAPI
1*
1Institute of Immunology & Infection Research, School of Biological Sciences, University of Edinburgh, Ashworth
Laboratories, King’s Buildings, West Mains Rd, Edinburgh, EH9 3JT, UK
2Area de Parasitología, Dept. Biologia Cellular i Parasitologia, Universitat de València, Av. V.A. Estellés, s/n, 46100
Burjassot (Valencia), Spain
3Institute of Infection, Immunity and Inﬂammation College of Medical, Veterinary and Life Sciences, Joseph Black
Building, University of Glasgow, G12 8QQ, UK
4Parasitology Laboratory, Instituto de Recursos Naturales y Agrobiología de Salamanca (IRNASA, CSIC), Cordel de
Merinas, 40-52, 37008 Salamanca, Spain
5Unidad de proteómica-SCIE, Universitat de València, Dr Moliner, 50, 46100 Burjassot (Valencia), Spain
6Centre for Neglected Tropical Disease Control, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK
(Submitted 5 November 2010; Revised 31 January and 10 February 2011; accepted 10 February 2011; first published online 10 June 2011)
SUMMARY
With the current paucityofvaccine targets for parasiticdiseases, particularly thosein childhood, the aimof this study wasto
compare protein expression and immune cross-reactivity between the trematodes Schistosoma haematobium, S. bovis and
Echinostoma caproni in the hope of identifying novel intervention targets. Native adult parasite proteins were separated by
2-dimensional gel electrophoresis and identiﬁed through electrospray ionisation tandem mass spectrometry to produce a
reference gel. Proteins from diﬀerential gel electrophoresis analyses of the three parasite proteomes were compared and
screenedagainstserafromhamsters infectedwithS.haematobiumandE.capronifollowing2-dimensional Westernblotting.
Diﬀerential protein expression between the three species was observed with circa 5% of proteins from S. haematobium
showing expression up-regulation compared to the other two species. There was 91% similarity between the proteomes of
the two Schistosoma species and 81% and 78·6% similarity between S. haematobium and S. bovis versus E. caproni,
respectively.Althoughthereweresomecommoncross-speciesantigens,species-speciestargetswererevealedwhich,despite
evolutionary homology, could be due to phenotypic plasticity arising from diﬀerent host-parasite relationships.
Nevertheless, this approach helps to identify novel intervention targets which could be used as broad-spectrum candidates
for future use in human and veterinary vaccines.
Key words: Schistosoma, S. bovis, S. haematobium, Echinostosma caproni, trematode, proteomics, immunology, DIGE,
DIA, vaccine development.
INTRODUCTION
Schistosomes are important blood-ﬂuke parasites of
humans and domestic livestock (Rollinson et al.
1997). These trematodes are divided into 4 main
groups: Schistosoma mansoni group, S. haematobium
group, S. indicum group and S. japonicum group
(Secor and Colley, 2005). Echinostomes are also
trematodes but, unlike schistosomes, they develop
and are restricted to the intestinal lumen of the
deﬁnitive host and do not have a tissue invasive phase
(Toledo and Fried, 2005; Toledo et al. 2009).
Human schistosomiasis is a neglected tropical
disease and a major public health concern in Africa,
the Middle East, Asia and South America. Some
200 million people are infected with schistosomes,
with a further 700 million at risk of infection in
tropical and subtropical regions (Engels et al. 2002).
As there is currently no available vaccine for this
disease in people (Bergquist et al. 2008), the foun-
dation of control is based upon provision of chemo-
therapy to aﬄicted communities, in particular mass
drug administration of the anthelmintic praziquantel
(Doenhoﬀ et al. 2009). However, the search for an
eﬀective vaccine continues to be a key priority (Secor
and Colley, 2005).
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doi:10.1017/S0031182011000412Urinary schistosomiasis, caused by Schistosoma
haematobium, is the most prevalent form of schisto-
somiasis in Africa and the Middle East. Children
carry the heaviest burden of infection with as many
as 100% of primary school children infected in
areas such as our study sites in Zimbabwe (Midzi
et al. 2008). Children younger than school-age can
also be infected and begin to exhibit disease (Garba
et al. 2010). As a result, schistosome-related morbid-
ities include both non-immunological forms (blood
in the urine, pain during urination, anaemia, growth
retardation, poor cognition and memory) and im-
mune-mediated forms (tissue damage and organo-
megaly) (Midzi et al. 2008). Immuno-pathological
reactions against schistosome eggs trapped in the
tissues leads to inﬂammatory and obstructive dis-
ease in the bladder, ureter and kidney as well as
ﬁbrosis. Urinary schistosomiasis likely predisposes
to bladder cancer and HIV infection (Stoever et al.
2009).
To develop vaccines protective against infection
and/or pathology based on naturalimmune responses
against schistosomes, there is ongoing research both
in humans and animals in a context of experimen-
tal and natural schistosomiasis (Hagan et al. 1991;
Dunne et al. 1992; Demeure et al. 1993; Grogan
et al. 1997; Mutapi et al. 1998). Several studies
have demonstrated similarities between diﬀerent
Schistosoma species in terms of life-histories and
immunological aspects (Verjovski-Almeida et al.
2003; Capron et al. 2005; Berriman et al. 2009;
Zhou et al. 2009), but little is known about molecular
phenotypic diﬀerences that may be involved in
host adaptation which might aﬀect the eﬃcacy of
future vaccines. Despite the demonstration that
antibody-mediated responses can protect against
schistosome infection in experimental models, cur-
rent human schistosome vaccine research, based on
antibody-mediated protection, has stalled with the
failure of many of the vaccine candidate antigens
to enter Phase III clinical trials (Hagan and Sharaf,
2003). Limitations in our current understanding
of the development of protective anti-schistosome
responses against speciﬁc antigenic proteins as
well as the parasite’s biology (particularly antigen
expression patterns) may be contributing to the
slow development of eﬀective anti-schistosome
vaccines.
To shed light on these issues, comparison of the
protein expression of S. haematobium adult worms
with other trematode parasites could be illuminat-
ing especially in reference to S. bovis which is a
‘molecular’ analogue of S. haematobium and an
experimental model for vaccine research (Capron
et al. 2005). Comparison with other more distantly-
related trematodes, e.g. Echinostoma caproni, is
also useful by providing inferences into putative
responses to diﬀerent life history tracts, i.e. echinos-
tomesdonothaveatissuephaseinthedeﬁnitivehost,
andpresentanopportunitytoinvestigatehost-related
adaptations in protein expression patterns. Although
S. bovis and S. haematobium diﬀer in their deﬁnitive
hosts and in their niches within the host vasculature
(Vercruysse and Gabriel, 2005), being suﬃciently
closely related in terms of evolutionary distance
(Bowles et al. 1995; Webster et al. 2006), they have
an ability to hybridise (Huyse et al. 2009). As S. bovis
ismucheasiertokeepinlaboratorypassageinrodents
(Agnew et al. 1989) as well as eliciting similar
cross-immunogenic proﬁles (Losada et al. 2005),
makes study of S. bovis particularly informative.
However, signiﬁcant diﬀerences are known: for
example, early studies of the S. haematobium vaccine
candidate glutathione-S-transferase (28 kDa GST)
showed inter-species variation in the coding regions
of S. haematobium vs. S. bovis vs. S. japonicum
28 kDa GST. This variation gives rise to phenotypic
diﬀerences associated with host immunity (Trottein
et al. 1992).
To date, several studies using proteomic ap-
proaches have compared protein expression patterns
between diﬀerent helminth life stages (Curwen et al.
2004; Jolly et al. 2007; Wang et al. 2010), including
parasites of diﬀerent sexes and parasite develop-
ment in diﬀerent hosts (Toledo et al. 2004; Cheng
et al. 2005). There have been no comparative
proteomic studies on diﬀerent trematode species
which could lead to novel intervention targets with
broader spectra and a better understanding of
parasite-related host immune modulation (Harnett
and Harnett, 2010). Previous evolutionary and
ecological studies have been carried out using genetic
techniques such as micro-array (transcriptome) or
genome sequencing (Cieslak and Ribera, 2009) and
these have given important insights into the biology
of the parasites. These techniques do not take into
account post-transcriptional regulation of protein
expression (López, 2007; Schrimpf and Hengartner,
2010) and cannot determine the degree of epitope
cross-reactivity between parasite species. Moreover,
the proteomic approach is particularly useful in
non-model organisms (López, 2007; Ramm et al.
2009). Comparative proteomic approaches have been
successfully used in other more general molecular
studies: for example, assessing the divergence be-
tween diﬀerent rodent species (Aquadro and Avise,
1981).
In this study, we have used a proteomic approach
to compare phenotypic diﬀerences between the three
diﬀerent parasite species in terms of protein ex-
pression and immunogenicity. We compared protein
expression patterns and immune cross-reactivity
between S. haematobium, S. bovis and E. caproni
which may indicate proteins involved in the ad-
aptation to diﬀerent hosts and diﬀerent niches
potentially warranting further scrutiny as potential
vaccines targets for schistosomiasis as well as several
other trematode diseases.
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Parasites and experimental infections
The techniques used for the maintenance of
Echinosotoma caproni in the laboratory have been
described in detail elsewhere (Toledo et al. 2004).
Brieﬂy, encysted metacercariae of E. caproni were
removed from the kidneys and pericardial cavities of
experimentally infected Biomphalaria glabrata snails
and used to infect golden hamsters (Mesocricetus
auratus). Outbred male golden hamsters, weighing
45–60 g, were infected through a stomach tube with
75 metacercariae each of E. caproni. The worm egg
release by each animal was monitored daily as
described previously (Toledo et al. 2003). Soluble
adult worm antigens (SWAP) were prepared from
adult worms collected from the intestine of hamsters
6 weeks post-infection with 100 metacercariae of
E. caproni following previously published protocols
(Toledo et al. 2003). For S. haematobium infections
used for the serological studies, parasite eggs
obtained from urine of S. haematobium-infected
children in Zanzibar (Stothard et al. 2002) were
hatched and used to infect Bulinus wrighti snails with
5 miracidia per snail. Upon infection patency 150
cercariae were pooled from these shedding snails and
used to infect golden hamsters by the paddling
technique; all experiments were in accordance with
ethical principles in animal research and Home Oﬃce
(UK) approvals.
Adult S. haematobium SWAP was obtained freeze
dried from the Theodor Bilharz Institute (Giza,
Egypt). To prepare this fraction, worms were
perfused in saline buﬀer from hamsters, washed in
PBS (pH 7·4), homogenized, centrifuged to obtain
the soluble fraction and freeze-dried in aliquots
(5 mg/mL). These were reconstituted with distilled
water as required. Freeze-dried adult S. bovis SWAP
from sheep was prepared as previously described in
detail elsewhere (Oleaga and Ramajo, 2004). SWAP
preparations were prepared following similar proto-
cols to reduce proteome variations due to diﬀerent
preparation approaches.
Rodent sera
For the immunological cross-reactivity assays, the
antigen recognition patterns of sera from hamsters
infected with S. haematobium and E. caproni were
determined. For E. caproni, a pool was made from
sera collected at 5, 6 and 10 weeks post-infection
(hamsters normally make parasite-speciﬁc antibodies
from 5 weeks) from 5 hamsters. After clotting
overnight at 4 °C, serum was separated from the
clot by centrifugation. All the sera and the antigens
were stored at −20 °C until use. For sera from
schistosome infected hamsters, Syrian golden ham-
sters were infected with 150 cercariae by paddling
and bled 12 weeks post-infection. After clotting,
blood collected from each hamster was centrifuged
at 1400 g for 5 min to collect sera which were snap
frozen in liquid nitrogen for long-term storage in
liquid nitrogen. A pool of sera was made from
5 hamsters for use in this study. There were no
experiments of hamsters infected with S. bovis
parasites.
Preparations for CyDye labelling for DIGE
CyDye DIGE Fluor minimal dyes (GE Healthcare)
were reconstituted following the manufacturer’s
instructions. 50μg protein of each sample were
labelled with either Cy3 or Cy5. The sample volumes
wereadjustedto18μLwithlabellingbuﬀer(7Murea,
2M thiourea, 4% CHAPS, (w/v), 25 mM Tris Base;
pH 8·5), followed by addition of 1μL dye (400 pmol)
to each individual sample. The samples were left on
ice for 30 minutes in the dark, followed by adding
1μL of 10 mmol/L lysine to stop the reaction.
Two-dimensional diﬀerential in gel electrophoresis
(2D-DIGE)
To compare the parasite proteomes in 2D-DIGE
assays, three gels were ran–one for each pair of
samples. Diﬀerentially labelled samples were mixed
into the same tube with 210μl of rehydration buﬀer
(7M urea, 2M thiourea, 4% CHAPS, 5% DTE
(dithioerythritol), 0·8% IPG buﬀer 3–10 pH and
bromophenol blue). Thereafter, the ﬁrst dimension
i.e. isoelectric focusing (IEF) and second dimension
were run following previously described protocols
(Mutapi et al. 2005) using the IEF protocol for 13 cm
IPG strips; rehydration for 14 h at 20 V, 500 V for
1 h, 1000 V for 1 h and 8000 V for 3h and performing
the second dimension using 12% polyacrylamide gels
with SDS buﬀer. Images from these gels were
subsequently analysed as described below.
Image analysis and mass spectrometry
Gels were scanned on a Typhoon spectrophotometer
(GE Healthcare) at the appropriate excitation/emis-
sion wavelength for each ﬂuorophore Cy3 (532/
580 nm) and Cy5 (633/670 nm) at 50 microns
resolution. The images were analyzed using the
Diﬀerence In–gel Analysis (DIA) module of
Decyder software version 7.0 (GE Healthcare). The
protein spots showing greater than 5-fold diﬀerences
in relative abundance between parasite preparations
were considered as diﬀerentially expressed proteins.
The 5-fold diﬀerence was used to reduce the like-
lihood of detecting spurious diﬀerences. Proteins
from the diﬀerent trematodes were identiﬁed by
comparing DIGE images with the proteomic map of
S. haematobium (Mutapi et al. 2005) and E. caproni
(Sotillo etal.2010)since thereisnocompletegenome
1609 Screening trematodes for novel intervention targetsFig. 1. 2D-DIGE images comparing pairs of diﬀerent helminth species’ adult worm proteomes.
A. S. haematobium (green spots) vs. S. bovis (red spots).
B. S. haematobium (red spots) vs. E. caproni (green spots).
1610 Melissa Higón and othersor protein sequence available for any of the three
species studied. S. haematobium protein identities on
the proteome map were obtained from a Coomassie
Blue-stained reference gel which had been prepared
and processed to obtain MS/MDS data which were
submitted for an MS/MS ion search via the Mascot
search engine (Matrix Science), and non-redundant
National Center for Biotechnology Information
(NCBI) database (Mutapi et al. 2005). Brieﬂy,
plugs of 1·4mm were excised from the reference
Coomassie Blue-stained gel and subjected to in-gel
trypsin digestion in an Ettan Spot Handing
Workstation (GE Healthcare), in accordance with
standard protocols (Amersham).
The resulting tryptic peptides were solubilized in
0·5% formic acid and were fractionated by nanoﬂow
high-performance liquid chromatography on a C18
reverse phase column (GE Healthcare), and elution
was performed with a continuous linear gradient of
40% acetonitrile for 20min. The elutants were
analyzed by online electrospray tandem MS (MS/
MS) by use of a Qstar Pulsar mass spectrometer
(Applied Biosystems). A 3 sec survey scan preceded
each MS/MS data-collection cycle of 4 product ion
scans of 3 sec each, and this gave a duty cycle of
15 sec. Data were submitted for an MS/MS ion
searchviatheMascotsearchengine(MatrixScience),
and both locally established databases for S. mansoni
EST sequences and the present non-redundant
National Center for Biotechnology Information
(NCBI) database were searched.
Two-dimensional electrophoresis and Western blotting
In order to determine cross-reactive antigens, 2D gel
electrophoresis (2DE) was conducted on 7 cm gels as
above, with some modiﬁcations. 100 μg of protein
were solubilised in rehydration buﬀer (7 M urea, 2 M
thiourea, 4% CHAPS (w/v), 65 mM DTE and trace
bromophenol blue) and 0·8% IPG buﬀer (pH 3–10)
to make a total volume of 125μL. Each protein
preparation was then added to a 7 cm linear pH 3–10
IPG strip and the IEF was performed following the
following protocol (1) passive rehydration for 14 h ;
(2) 500 V for 30 min; (3) 1000 V for 30 min;
(4) 8000 V for 4 h followed by equilibration in 2 mL
of1%DTEfor15 minand2 mLof4%iodoacetamide
in equilibration buﬀer containing 6 M urea, 0·375 M
Tris pH 8·8, 2% SDS and 20% glycerol. The second
dimension was performed using 10% polyacrylamide
precast gels from Invitrogen. Proteins from SDS–
PAGE were stained with Coomassie blue or trans-
ferred onto nitrocellulose membranes in 25 ml 20X
transfer buﬀer (Invitrogen), methanol 10% (v/v).
After conﬁrming transfer by staining with 0·1%
Ponceau S (Sigma), membranes were blocked with
TBS Start Block buﬀer T20 (Invitrogen) for 1 h at
room temperature. After washing with TBS contain-
ing 0·05% Tween-20 (TBST), blots were incubated
overnight at 4°C with a pool of 10 serum samples
of E. caproni-infected hamsters, or S. haematobium-
infected hamsters or negative control sera at 1:200
dilution in TBS Start Block buﬀer. The membrane
was then washed three times for 10 min each time in
TBS, 0·05% Tween 20, 0·5% Triton-X100 (TBS/
TT). Bound antibodies were detected by incubating
blots for 1h at RT with horseradish peroxidase
(HRP)-conjugated rabbit anti-Syrian hamster IgG
(Abcam), in blocking buﬀer. After washing four
times for 10 min each time in TBS/TT and once
in TBS alone, recognised antigens were visualized
using ECL Plus (Amersham) following the manu-
facturer’s instructions, and exposed to X-OMAT
ﬁlm (Kodak) for 10 sec. Images from Western
blotting and Coomassie blue staining were digitalised
and matched by using ImageMaster software (GE
Healthcare).
RESULTS
Proteome comparisons
The 2D-DIGE gels were run comparing the 3
proteomes as shown in Fig.1. DIA analysis of the
gels showed both quantitative and qualitative diﬀer-
ences. There was more similarity between the two
schistosome species than between Echinostoma and
Schistosoma. On the ﬁrst gel comparing S. haemato-
bium and S. bovis, 1701 spots representing diﬀerent
proteins(including diﬀerentisoforms) weredetected,
with 91% showingsimilarexpression levels (Fig. 2A).
5·4% of the proteins showed increased expression in
S. haematobium by our criteria of 5-fold or greater
diﬀerenceinabundance onthegelwhile 3·6%showed
increased expression in S. bovis. On the second gel,
comparing S. haematobium vs. E. caproni, 1967 spots
were detected with 81% showing similar expression
levels. 8·4% of the protein spots showed increased
expression in S. haematobium and 10·6% showed
increased expression in E. caproni while 81% were
present in similar amounts on both gels (Fig. 2B).
On the ﬁnal gel, comparing S. bovis vs. E. caproni,
1757 spots were detected with 78·6% showing
similar expression levels. 9·1% of the protein spots
showed increased expression in S. bovis and 12·3%
showed increased expression in E. caproni (Fig. 2C).
It was possible to identify some of the proteins
present on the adult worm proteomes by comparing
DIGE images with the proteomic maps of
C. S. bovis (red spots) vs. E. caproni (green spots).Identiﬁed proteins are indicated by solid arrows (for S. haematobium),
dashed arrows (for E. caproni) and encircled (for both).
1611 Screening trematodes for novel intervention targetsFig. 2. Pair-wise comparison of protein expression patterns in adult worm proteomes of pairs of parasite species from
DIA plug-in analysis. This analysis co-detects the spots from the image and, after normalization, compares the volume
1612 Melissa Higón and othersS. haematobium and E. caproni. Details of
S. haematobium protein identities from mass spec-
trometry of proteins have already been published
(Mutapi et al. 2005) while those from E. caproni have
not previously been published and are given in
Table 1 and annotated in Fig. 3.
The expression patterns of pairs of proteins spots
between diﬀerent parasite species are compared in
Table 2. The heat shock protein HSP70 was more
highly expressed in S. haematobium compared to
S. bovis or E. caproni. Between the Schistosoma
species, there were similar expression levels of meta-
bolic enzymes, signal transduction molecules and
detoxiﬁcation enzymes, but expression levels of these
proteins diﬀered between the latter species and
E. caproni. Three homologous proteins were ident-
iﬁed in S. haematobium and E. caproni; protein
disulﬁde isomerase, enolase and GST, but the gel
migration showed that they diﬀered in molecular
weights between the two species.
Immune cross-reactivity
Using sera from hamsters infected with S. haemato-
bium and E. caproni, we performed 2D Western-
blot analyses. As expected, homologous pairs of
sera and antigen showed the highest levels of
recognition (Fig. 4). Interestingly, heterologous sera
also detected spots in the gels, conﬁrming cross-
reactivity among these trematode species. In this
context, S. haematobium sera recognised more anti-
genic spots in the S. bovis proteome than in
E. caproni. There was some cross-reactivity, be-
tween E. caproni and S. haematobium. Three spots in
the E. caproni proteome which were identiﬁed as
isoforms of GADPH reacted with sera from both
E. caproni-infected and S. haematobium-infected
hamsters. However, sera from E. caproni-infected
hamsters did not react against GADPH in the
S. haematobium proteome.
DISCUSSION
Trematodes are an evolutionarily distinct group
of parasites of importance to both human and
veterinary medicine in the diseases that they cause.
Understanding similarities and diﬀerences in their
phenotypic molecular biology is important in several
areas such as drug target discovery, vaccine design
and development of helminth-derived therapeutic
agents for immune disorders; also in the context of
when infections are acquired during childhood and
beyond.Here,acomparativeanalysisofthe proteome
of three species of trematode: S. haematobium,
of a spot from the two samples as a volume ratio. Spots were detected as diﬀerent if the volume ratio threshold diﬀerence
was 5 5 fold. Each gel image shows diﬀerent expression patterns on individual species gels.
A. Gels showing the DIA analyses of S. haematobium vs. S. bovis on the gels from each of the two species. Green marks
represent proteins over-expressed in S. haematobium. Red marks represent proteins over-expressed in S. bovis. Blue
represents spots expressed to similar levels in the two species.
B. Gels showingthe DIAanalyses ofS. haematobium vs.E. capronionthe gelsfromeachofthe twospecies. Greenmarks
represent proteins over-expressed in S. haematobium. Red marks represent proteins over-expressed in E. caproni. Blue
represents spots expressed to similar levels in the two species.
C. Gels showing the DIA analyses of S. bovis vs. E. caproni on the gels from each of the two species. Green marks
represent proteins over-expressed in E. caproni. Red marks represent proteins over-expressed in S. bovis. Blue represents
spots expressed to similar levels in the two species.The histograms represents spot frequencies plotted against logarithm
volume ratio.
Table 1. Proteins identiﬁed in the adult soluble worm preparation of Echinostoma caproni using MASCOT
search engine (Matrix Science)
Sample NCBI accession # Protein (Species) MW Hit_score
1 gi|3891573 Chain A, Fasciola hepatica Glutathione S-transferase isoform 1 in
complex with glutathione
25217 77
2 gi|3891573 Chain A, Fasciola hepatica Glutathione S-transferase isoform 1 in
complex with glutathione
25217 83
3 gi|16406594 Glyceraldehyde phosphate dehydrogenase (Fasciola hepatica) 23687 247
4 gi|16406594 Glyceraldehyde phosphate dehydrogenase (Fasciola hepatica) 23687 201
5 gi|226475754 Aldolase (Schistosoma japonicum) 39800 134
6 gi|29841453 Similar to GenBank Accession Number AF026805 fructose
bisphosphate Aldolase (S. mansoni and S. japonicum)
32063 162
7 gi|268535422 Hypothetical protein CBG15039 (Caenorhabditis briggsae) 20029 58
8 gi|112950027 Enolase (Echinostoma caproni) 46568 588
9 gi|226489288 Tubulin beta-2C chain (Schistosoma japonicum) 50056 666
10 gi|3392892 Protein disulphide isomerase (Fasciola hepatica) 55587 69
1613 Screening trematodes for novel intervention targetsS. bovis and E. caproni using 2D-DIGE was con-
ducted. S. haematobium and S. bovis are closely
related species and can undergo hybridisation (Huyse
et al. 2009), the results obtained here show that there
arealsosigniﬁcantproteomicdiﬀerences,evenamong
conservedproteins.Thesespecies-speciﬁcdiﬀerences
could be due to phenotypic plasticity arising from
diﬀerent host-parasite relationships (Schrimpf and
Hengartner, 2010). Evolutionary and phylogenetic
studies have demonstrated that highly expressed
genes tend to evolve more slowly (Hirsh and Fraser,
2001; Schrimpf and Hengartner, 2010), nonetheless
here we demonstrate that some of these conserved
proteinsdiﬀerinmolecular weight,mostlikelydueto
post-translational modiﬁcations which should be
explored further particularly as vaccine candidates.
It was possible to identify some of the proteins
present in the proteomes by searching public
Table 2. Proteins diﬀerentially expressed between the diﬀerent trematodes identiﬁed on the 2-dimensional
gel in Diﬀerential in Gel Electrophoresis (DIGE)
S. haematobium vs. S. bovis
INCREASED in S. haematobium
Heat shock protein /chaperone NCBI accession # MW
70,000 mol wt antigen/hsp70 gi|10168 68331
SIMILAR
Metabolic enzyme NCBI accession # MW
Triosephosphate isomerase gi|1351281 28447
Fructose 1,6 bisphosphate aldolase gi|605647 39963
Protein disulﬁde isomerase gi|312018 54463
Phosphoglycerate kinase gi|556413 44508
Enolase gi|3023710 47421
Heat shock protein/chaperone
Heat shock protein HSP60 gi|21634531 58740
Signal transduction
14−3-3 epsilon gi|6649234 28754
Detoxiﬁcation protein
28 kDa glutathione-S transferase gi|161013 2407
S. haematobium vs. E. caproni
INCREASESD in S. haematobium
Metabolic enzyme NCBI accession # MW
Triosephosphate isomerase gi|1351281 28447
Fructose 1,6 bisphosphate aldolase gi|605647 39963
Protein disulﬁde isomerase gi|312018 54463
Phosphoglycerate kinase gi|556413 44508
Enolase gi|3023710 47421
Heat shock protein /chaperone
70,000 mol wt antigen/hsp70 gi|10168 68331
Heat shock protein HSP60 gi|21634531 58740
Signal transduction
14-3-3 epsilon gi|6649234 28754
Detoxiﬁcation protein
28 kDa glutathione-S transferase gi|161013 24071
INCREASED in E. caproni
Metabolic enzyme NCBI accession # MW
Protein disulphide isomerase gi|3392892 55587
Enolase gi|112950027 46568
Glyceraldehyde phosphate dehydrogenase gi|16406594 23687
Detoxiﬁcation protein
Glutathione S-Transferase gi|3891573 25217
SIMILAR
Metabolic enzyme NCBI accession # MW
Aldolase gi|226475754 39800
E. caproni vs. S. bovis
INCREASED in E. caproni
Metabolic enzyme NCBI accession # MW
Protein disulphide isomerase gi|3392892 55587
Enolase gi|112950027 46568
Glyceraldehyde phosphate dehydrogenase gi|16406594 23687
Detoxiﬁcation protein
Glutathione S-Transferase gi|3891573 25217
1614 Melissa Higón and othersdatabases, but due to the limited sequence infor-
mation available on these three trematodes, a large
number of the proteins remain unidentiﬁed (Nowak
and Loker, 2005). Comparing the proteomes of the
two schistosome species, only HSP70 identiﬁed from
the Coomassie Blue-stained reference gel showed
increased expression in S. haematobium despite the
10% diﬀerence in protein expression levels detected
by the DIA analysis. The DIGE analysis can detect
much lower concentrations of proteins than
Coomassie staining.Thus, alarge numberofproteins
present on the DIGE gel were present at a concen-
tration too low to be detected from the Coomassie
Blue-stained gel for mass spectrometry. These
proteins accounted for some of the 10% diﬀerences
between the two schistosomes. Our results showing
diﬀerential expression of HSP70 are consistent with
those from a diﬀerent trematode genus, Fasciola
where F. hepatica and F. gigantica show diﬀerent
levels of HSP70 expression (Smith et al. 2008).
Furthermore we have previously reported diﬀerences
in HSP70 expression in E. caproni parasites from low
vs. high compatible hosts (Higón et al. 2008).
Therefore, expression levels of HSP70 seem to
depend on the host environment and this could be a
common mechanism used by diﬀerent parasites in
order to adapt to diﬀerent hosts. The sequencing of
the genome and subsequent identiﬁcation of all
proteins present in the proteome of all 3 species
compared in this study will greatly strengthen such
comparative approaches as they will allow more
robust comparison of identiﬁed proteins as well as
comparisons of the number of isoforms and the
relative abundance of each isoform to the compared.
There were more diﬀerentially expressed proteins
between the two diﬀerent genera. Most proteins
identiﬁed in both E. caproni and S. haematobium
(with known identities) are homologues (protein
disulﬁde isomerase, enolase and GST). However,
these homologues have diﬀerent molecular weights.
It is likely that this diﬀerence is due to post-
translational modiﬁcations rather than changes in
the gene sequence, since these proteins are highly
conserved (Ramajo-Hernández et al. 2007a,b; Sotillo
et al. 2008). Furthermore, these proteins are impor-
tant for the host-parasite relationship (E/S products,
immunogenic properties), so these modiﬁcations
could be involved in the host-parasite surface inter-
action. Protein disulﬁde isomerase (PDI) catalyses
the formation (oxidation), breakage (reduction) and
rearrangement (isomerisation) of disulﬁde bonds
withinproteins,therebypermittingtheirproperfold-
ing in the endoplasmic reticulum and transit through
the secretory pathway (Ellgaard and Ruddock, 2005).
PDI has been identiﬁed in the E/S products of
adult E. caproni, E. friedi and F. hepatica worms,
suggesting that it may be important in host-parasite
interactions (Salazar-Calderon et al. 2003; Bernal
et al. 2006; Sotillo et al. 2010). Moreover, PDI is
immunogenic in human S. haematobium infections
(Mutapi et al. 2005) and experimental F. hepatica
(Moxon et al. 2010) and it has been shown to be
immunologically protective against the hookworm,
Ancylostoma (Epe et al. 2007). Diﬀerences in PDI
kDa
Fig. 3. Coomassie blue-stained 2-dimensional E. caproni gel showing spots excised, and identiﬁed by MASCOT.
Corresponding protein identities are given in Table 1.
1615 Screening trematodes for novel intervention targetsFig. 4. Antigen recognition proﬁle of sera from trematode-infected hamsters.
A. S. bovis SWAP antigen recognition by sera from E. caproni-infected hamsters.
B. S. bovis SWAP antigen recognition by sera from S. haematobium-infected hamsters.
1616 Melissa Higón and othersmolecular weight between S. haematobium and
E. caproni could be due to post-translational mo-
diﬁcations, akin to the PDI glycosylation reported in
Trypansoma brucei where it is related to parasite
defence (Rubotham et al. 2005).
The main function of glutathione S-transferase
(GST) is detoxiﬁcation of oxygen and endogenous
free radicals (Torres-Rivera and Landa, 2008). It is
present in Echinostoma spp. and S. bovis tegument
and E/S products (Bernal et al. 2006; Perez-Sanchez
et al. 2006; Sotillo et al. 2010). It is also the leading
schistosome vaccine candidate (Capron et al. 2005;
McManusandLoukas,2008).Thereisadiﬀerencein
the theoretical and observed molecular weights for
GST. Ramajo-Hernandez et al.( 2007a) reported no
glycosylation of GST in S. bovis. Enolase is a multi-
functional glycolytic enzyme (Pancholi, 2001), also
present in E/S products (Bernal et al. 2006; Perez-
Sanchez et al. 2006; Sotillo et al. 2010). In S. bovis as
well as E. caproni, enolase has been identiﬁed as a
human plasminogen-binding protein; this protein
may be involved in preventing blood clotting during
feeding in Schistosoma (Ramajo-Hernández et al.
2007b)orinmucosalerosioninEchinostoma(Marcilla
et al. 2007).
To investigate some of the biological diﬀerences
arising from diﬀerences in the proteomes, the im-
munogenicity of the adult worm antigens was
compared. There was cross-reactivity between the
threetrematode species, but the intensity and antigen
pattern recognition patterns diﬀered. The most im-
mune cross-reactivity occurred between the two
schistosomes which is consistent with the DIGE
results. We have identiﬁed a novel antigen for
E. caproni, 3 isoforms of GADPH. E. caproni
GAPDH was also recognized by sera from
S. haematobium-infected hamsters. Interestingly,
S. haematobium GADPH antigen was not recognized
byserafromE.caproni-infectedhamsters.GAPDH’s
immunogenicity has been reported from other
studiesand is one of the World Health Organisation’s
human schistosome vaccine candidates (Bergquist
et al. 2002; El Ridi et al. 2010). Nevertheless it has
not previously been reported as an antigen in
Echinostoma spp. Toledo et al. (2004) discovered an
immunogen of 37 kDa, 6 weeks post Echinostoma
infections in rats, but the intensity of this response
declined during the infection, suggesting that the
protein could be released in the juvenile stages of
the parasites. This immunogen is likely to be
GAPDH and this present study and that of Toledo
et al. (2004) suggest that the kinetics of antigen
release and antibody production against GAPDH
require further investigation, especially in the future
contextofscreeningagainsthumanserafrominfected
people.
Schistosomiasis continues to be a major public
health problem in several tropical and sub-tropical
countries. There are now several studies (e.g. Garba
et al. 2010), showing that children as young as 1 year
old are infected and can harbour levels of infection
comparable to those in the adults in their commu-
nitiesand thesearchforaneﬀectivevaccinecontinues
to be a key priority (Secor and Colley, 2005). One
promising approach being pursued is to treat people,
children in particular, repeatedly with praziquantel
to induce immune-mediated resistance to re-infec-
tion (Black et al 2010a). However, studies using this
protocol indicate that the number of PZQ treatments
required to reduce re-infection is signiﬁcantly vari-
able and can take several rounds of PZQ treatment
(Black et al. 2010b). This suggests that an integrated
approach using treatment and a recombinant vaccine
as proposed by the World Health Organisation
(Berquist, 2004) might lend predictability and
consistency as well as improved eﬃcacy to future
schistosome control programmes. Thus the molecu-
lar phenotypic diﬀerences shown in this study, par-
ticularly those which appear to be post-translational,
may inﬂuence the development and production of
recombinant vaccines (e.g. bacterial expression sys-
tems may not process the proteins appropriately
after translation) and aﬀect the eﬃcacy of future
vaccines.
Overall this study has demonstrated that, despite
several biological and phylogenetic similarities be-
tween the three trematode species S. haematobium,
S. bovis and E. caproni, there are quantitative and
qualitative diﬀerences in protein expression patterns
in their adult worm proteomes. The diﬀerences
could be due to phenotypic plasticity arising from
diﬀerent host-parasite relationships. Some of these
diﬀerences translate to diﬀerences in immunogeni-
city. Further studies characterizing the diﬀerentially
expressed proteins will be important in determining
the identity of proteins involved in host-parasite
adaptation and the nature of the interaction be-
tween the host and parasite. This is particularly
important for identifying vaccine candidates and
predicting the eﬀects vaccination, especially in child-
hood, would have on the parasite population
structure.
C. S. haematobium SWAP antigen recognition by sera E. caproni from infected hamsters.
D. S. haematobium SWAP antigen recognition by sera from S. haematobium-infected hamsters.
E. E. caproni SWAP antigen recognition by sera from E. caproni-infected hamsters.
F. E. caproni SWAP antigen recognition by sera from S. haematobium-infected hamsters.
A novel E. caproni antigen GAPDH is encircled.
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